fbpx
Donate Toggle Menu

Dana Farber Recognizes $1 Million in KCA Research Support

The Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts recently recognized the Kidney Cancer Association (KCA) for supporting researchers at the institution with over $1 million in funding. KCA’s name was placed on the DFCI’s Benefactors…

Keith’s Cause is Small but Mighty

This is a guest post by Nicole Scott, whose husband Keith is diagnosed with kidney cancer. Together, they organize “Keith’s Cause” to raise awareness about kidney cancer where they live in Ohio. My name is…

Rare & Refractory Kidney Cancer Tumors: NCI Targets Both

This is a guest post by D’Ann George, PhD, Medical Writer. Some kidney cancers are so rare that clinicians don’t know enough about them to determine what treatments should be standard, or even to predict…

Michele Tate on Uterine Fibroids as a Biomarker for HLRCC

This is a guest post by Michele Tate. She is diagnosed with HLRCC and advocates for greater awareness and research into this rare genetic condition.   As we celebrate 2024 Black History Month and Rare…

The Joys that Cancer Can’t Rob

This is a guest post by Brandon Butera, a stage IV kidney cancer patient and advocate. He lives with his wife, Maggie Valdes, in Houston, Texas. Watch more of their journey. When we last gave…

Kidney Cancer Highlights from 2024 ASCO GU

We rounded up a few research highlights from the 2024 ASCO Genitourinary Cancers Symposium (ASCO GU), held recently in San Francisco, California. Adjuvant immunotherapy improved survival after nephrectomy and could be new standard of care Researchers are…

Join the 82K Challenge!

Every year, the Kidney Cancer Association hosts our signature Challenge event in cities across the US. The Challenge reflects the number of people estimated to be diagnosed with kidney cancer in a given year. In…

Expert Opinion: Key Trials from 2024 ASCO GU

This is a guest post by Dr. Arpita Desai, an oncologist at the University of California San Francisco specializing in genitourinary cancers. She summarized the results and takeaways for patients from key trials presented at…

1 3 4 5 6 7 33